Literature DB >> 26729873

Respiratory syncytial virus infection enhances Pseudomonas aeruginosa biofilm growth through dysregulation of nutritional immunity.

Matthew R Hendricks1, Lauren P Lashua1, Douglas K Fischer1, Becca A Flitter1, Katherine M Eichinger2, Joan E Durbin3, Saumendra N Sarkar4, Carolyn B Coyne1, Kerry M Empey2, Jennifer M Bomberger5.   

Abstract

Clinical observations link respiratory virus infection and Pseudomonas aeruginosa colonization in chronic lung disease, including cystic fibrosis (CF) and chronic obstructive pulmonary disease. The development of P. aeruginosa into highly antibiotic-resistant biofilm communities promotes airway colonization and accounts for disease progression in patients. Although clinical studies show a strong correlation between CF patients' acquisition of chronic P. aeruginosa infections and respiratory virus infection, little is known about the mechanism by which chronic P. aeruginosa infections are initiated in the host. Using a coculture model to study the formation of bacterial biofilm formation associated with the airway epithelium, we show that respiratory viral infections and the induction of antiviral interferons promote robust secondary P. aeruginosa biofilm formation. We report that the induction of antiviral IFN signaling in response to respiratory syncytial virus (RSV) infection induces bacterial biofilm formation through a mechanism of dysregulated iron homeostasis of the airway epithelium. Moreover, increased apical release of the host iron-binding protein transferrin during RSV infection promotes P. aeruginosa biofilm development in vitro and in vivo. Thus, nutritional immunity pathways that are disrupted during respiratory viral infection create an environment that favors secondary bacterial infection and may provide previously unidentified targets to combat bacterial biofilm formation.

Entities:  

Keywords:  Pseudomonas aeruginosa; biofilm; cystic fibrosis; nutritional immunity; respiratory syncytial virus

Mesh:

Substances:

Year:  2016        PMID: 26729873      PMCID: PMC4760822          DOI: 10.1073/pnas.1516979113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  A component of innate immunity prevents bacterial biofilm development.

Authors:  Pradeep K Singh; Matthew R Parsek; E Peter Greenberg; Michael J Welsh
Journal:  Nature       Date:  2002-05-30       Impact factor: 49.962

Review 2.  Cystic fibrosis pathogenesis and the role of biofilms in persistent infection.

Authors:  J W Costerton
Journal:  Trends Microbiol       Date:  2001-02       Impact factor: 17.079

3.  Airway iron and iron-regulatory cytokines in cystic fibrosis.

Authors:  D W Reid; Q T Lam; H Schneider; E H Walters
Journal:  Eur Respir J       Date:  2004-08       Impact factor: 16.671

4.  Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.

Authors:  H K Johansen; N Høiby
Journal:  Thorax       Date:  1992-02       Impact factor: 9.139

5.  Enhanced adherence of Streptococcus pneumoniae to human epithelial cells infected with respiratory syncytial virus.

Authors:  Jeanne-Marie Hament; Piet C Aerts; Andre Fleer; Hans Van Dijk; Theo Harmsen; Jan L L Kimpen; Tom F W Wolfs
Journal:  Pediatr Res       Date:  2004-04-21       Impact factor: 3.756

6.  Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds.

Authors:  P A Mickelsen; P F Sparling
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

7.  Respiratory infections in cystic fibrosis patients caused by virus, chlamydia and mycoplasma--possible synergism with Pseudomonas aeruginosa.

Authors:  N T Petersen; N Høiby; C H Mordhorst; K Lind; E W Flensborg; B Bruun
Journal:  Acta Paediatr Scand       Date:  1981-09

8.  Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis.

Authors:  A R Smyth; R L Smyth; C Y Tong; C A Hart; D P Heaf
Journal:  Arch Dis Child       Date:  1995-08       Impact factor: 3.791

9.  Haemophilus influenzae can use human transferrin as a sole source for required iron.

Authors:  D A Herrington; P F Sparling
Journal:  Infect Immun       Date:  1985-04       Impact factor: 3.441

10.  Siderophore-mediated iron acquisition from transferrin by Pseudomonas aeruginosa.

Authors:  S Sriyosachati; C D Cox
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

View more
  61 in total

1.  Cystic fibrosis and the war for iron at the host-pathogen battlefront.

Authors:  Nicole M Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-22       Impact factor: 11.205

2.  Viral Coinfection Replaces Effects of Suilysin on Streptococcus suis Adherence to and Invasion of Respiratory Epithelial Cells Grown under Air-Liquid Interface Conditions.

Authors:  Georg Herrler; Nai-Huei Wu; Peter Valentin-Weigand; Fandan Meng; Jie Tong; Désirée Vötsch; Ju-Yi Peng; Xuehui Cai; Maren Willenborg
Journal:  Infect Immun       Date:  2019-07-23       Impact factor: 3.441

3.  Volatile fingerprinting of Pseudomonas aeruginosa and respiratory syncytial virus infection in an in vitro cystic fibrosis co-infection model.

Authors:  Giorgia Purcaro; Christiaan A Rees; Jeffrey A Melvin; Jennifer M Bomberger; Jane E Hill
Journal:  J Breath Res       Date:  2018-07-03       Impact factor: 3.262

Review 4.  Biofilms 2018: A diversity of microbes and mechanisms.

Authors:  Clay Fuqua; Alain Filloux; Jean-Marc Ghigo; Karen L Visick
Journal:  J Bacteriol       Date:  2019-02-19       Impact factor: 3.490

Review 5.  Inflammation: A Double-Edged Sword in the Response to Pseudomonas aeruginosa Infection.

Authors:  Christina K Lin; Barbara I Kazmierczak
Journal:  J Innate Immun       Date:  2017-02-22       Impact factor: 7.349

6.  Peroxisome proliferator-activated receptor-γ agonists attenuate biofilm formation by Pseudomonas aeruginosa.

Authors:  Brahmchetna Bedi; Nicholas M Maurice; Vincent T Ciavatta; K Sabrina Lynn; Zhihong Yuan; Samuel A Molina; Myungsoo Joo; William R Tyor; Joanna B Goldberg; Michael Koval; C Michael Hart; Ruxana T Sadikot
Journal:  FASEB J       Date:  2017-04-25       Impact factor: 5.191

Review 7.  Type III IFNs: Beyond antiviral protection.

Authors:  Sergei V Kotenko; Amariliz Rivera; Dane Parker; Joan E Durbin
Journal:  Semin Immunol       Date:  2019-06       Impact factor: 11.130

Review 8.  Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease.

Authors:  Claire Healy; Natalia Munoz-Wolf; Janné Strydom; Lynne Faherty; Niamh C Williams; Sarah Kenny; Seamas C Donnelly; Suzanne M Cloonan
Journal:  Respir Res       Date:  2021-04-29

Review 9.  Pseudomonas aeruginosa polymicrobial interactions during lung infection.

Authors:  Karishma Bisht; Jiwasmika Baishya; Catherine A Wakeman
Journal:  Curr Opin Microbiol       Date:  2020-02-12       Impact factor: 7.934

10.  Expression of the Nontypeable Haemophilus influenzae Type IV Pilus Is Stimulated by Coculture with Host Respiratory Tract Epithelial Cells.

Authors:  Elaine M Mokrzan; Taylor J Johnson; Lauren O Bakaletz
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.